Examples of using Structure-based in English and their translations into Chinese
{-}
-
Political
-
Ecclesiastic
-
Programming
Structure-based Drug Discovery.
This drives rapid development of structure-based drug design.
Structure-based discovery of opioid analgesics with reduced side effects.
It has promoted the rapid development of the design of structure-based drug.
F structure-based testing: See white-box testing.
This has encouraged the rapid development of the structure-based drug design.
Structure-based methods have the great advantage of not needing experimental data.
Instead, McLellan and his colleagues took a new approach, called structure-based vaccine design.
Current methods for structure-based drug design can be divided roughly into two categories.
Instead, McLellan and his colleagues took a new approach, called structure-based vaccine design.
The partners have thus developed a structure-based design approach as a solid basis to accelerate further development.
The model, when refined,can be used to explore the mechanism of action of the protein and for structure-based drug design.
Structure-based PROTAC design promises to accelerate the development of therapies against currently intractable cancer drivers.
Computer-aided drug design(CADD) is of two types of structure-based drug design(SBDD) and ligand-based drug design(LBDD).
Meanwhile, the University of Maryland scooped up $6 million from the NIH todevelop a hep C vaccine with a“structure-based design.”.
Compared with the material-based damping technology, the special structure-based damping technology is more reflected in the design.
Another approach of structure-based drug design is about combinatorially mapping ligands, which is referred to as receptor-based drug design.
There are two approaches in leadidentification Ligand based drug designing(LBDD) and structure-based drug designing(SBDD).
Structure-based approaches generally rely on modeling the peptide-MHC structure followed by evaluation of the interaction through methods such as molecular dynamic simulations[8, 13].
Following her postdoctoral fellowship, she was a lab head at the Novartis Institutes for Biomedical Research,where she advanced multiple structure-based drug discovery programs.
Results published in Nature ChemicalBiology showcase the use of the broadly applicable structure-based PROTAC design approach to discover highly potent and selective drug candidates.
As the Head of the RTC Structural Biology, he oversaw a group of scientists responsible for protein production, characterization, crystallization,crystallography and structure-based drug design.
Dr. Nurulain Zaveri and colleages at Astraea Therapeutics, manufacturer of AT-121, used medicinal chemistry,computer modeling, and structure-based drug design to create and develop AT-121.